These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11584533)

  • 1. [Ketolide antibiotics. A new therapeutic option in respiratory tract infections].
    MMW Fortschr Med; 2001 Sep; 143(35-36):53-4. PubMed ID: 11584533
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 3. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
    Carter PL
    Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
    Reinert RR
    J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
    Lorenz J
    Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macrolides, ketolides and streptogramins].
    Mensa J; García-Vázquez E; Vila J
    Enferm Infecc Microbiol Clin; 2003 Apr; 21(4):200-7; quiz 208, 219. PubMed ID: 12681133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
    Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
    J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Telithromycin, first ketolide].
    Van Laethem Y; Sternon J
    Rev Med Brux; 2003 Feb; 24(1):42-6. PubMed ID: 12666494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telithromycin: a brief review of a new ketolide antibiotic.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(4):409-13. PubMed ID: 15303785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial airway infections. Standard antibiotics more often ineffective].
    MMW Fortschr Med; 2002 Feb; 144(8):52. PubMed ID: 11910829
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of new antibacterial therapies in at-risk populations.
    Lorenz J
    J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
    Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
    Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
    [No Abstract]   [Full Text] [Related]  

  • 17. Telithromycin in lower respiratory tract infections.
    Blasi F; Cazzola M; Tarsia P; Aliberti S; Baldessari C; Valenti V
    Future Microbiol; 2006 Jun; 1(1):7-16. PubMed ID: 17661681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to ketolide antibiotics by coordinated expression of rRNA methyltransferases in a bacterial producer of natural ketolides.
    Almutairi MM; Park SR; Rose S; Hansen DA; Vázquez-Laslop N; Douthwaite S; Sherman DH; Mankin AS
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):12956-61. PubMed ID: 26438831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance in respiratory tract infections. Ketolides: clinical aspects].
    Lorenz J; Steiert P
    Pharm Unserer Zeit; 2004; 33(1):42-6. PubMed ID: 14968712
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium.
    Verhaegen J; Verbist L
    Acta Clin Belg; 2001; 56(6):349-53. PubMed ID: 11881319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.